Sign in
4

Changes in Ownership

CytoDyn Inc. Filed Acc 0001104659-24-032609

Options or other derivatives

  • Chief Executive Officer acquired 3,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lalezari Jacob P Chief Executive Officer 2024-03-07 Grant or award · Non-qualified stock option (right to buy) +3,000,000 3,000,000 D: show line 1 in the form
Loading xslF345X05/tm248303-1_4seq1.xml…